comprehensive -WSS

comprehensive

author：explore 2025-10-01 11:33:07 - browse：7

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

entertainment

explore

WSS

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

For longer

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Investigation reveals sickle cell patients pressured into sterilizations

Cue Health, Covid

Pfizer highlights cancer drugs it thinks could reignite investor interest

explore

comprehensive

focus

What does generative AI mean for health care? We asked experts

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Investigation reveals sickle cell patients pressured into sterilizations

Affirmative action in medical school literally saved lives

Clinical trials giant ICON acquires HumanFirst

Heart attack and stroke risk calculators need revising

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

focus

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Why getting cancer drugs just got harder for rural patients

Scrutiny of post

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

H5N1 virus can be tracked in retail milk, scientists say

Change Healthcare cyberattack outage could last weeks

hotspot

entertainment

explore

Wikipedia